Method for expressing and purifying protein by using csq-tag
US-2024209046-A1 · Jun 27, 2024 · US
US9315782B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9315782-B2 |
| Application number | US-201113574458-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 19, 2011 |
| Priority date | Jan 20, 2010 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Water-forming NADH oxidase derived from Streptococcus mutans should be further improved in terms of stability for practical use in industrial production. An object of the present invention is to provide an enzyme that is obtained through modification of a water-forming NADH oxidase, which is useful as an NAD+ regeneration system for stereoselective oxidation catalyzed by an oxidoreductase, by protein engineering techniques so that the enzyme can withstand long-term use without exhibiting a reduction of its activity for the regeneration of NAD+, that is, an enzyme having improved stability, and to provide a method for efficiently producing a useful substance such as an optically active alcohol or amino acid. The present invention relates to an enzyme modification method that can improve the stability of water-forming NADH oxidase derived from Streptococcus mutans by appropriately introducing mutation.
Opening claim text (preview).
The invention claimed is: 1. An isolated DNA encoding a protein which has NADH oxidase activity or NADPH oxidase activity or both and has improved stability compared to the protein having the amino acid sequence of SEQ ID NO: 1, and wherein said protein has an amino acid sequence that has at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 1 and further contains at least one amino acid substitution selected from (a) to (g): (a) a substitution of an amino acid residue at a position corresponding to position 42 of SEQ ID NO: 1 with an amino acid having a side-chain surface area of 100 to 200 Å 2 ; (b) a substitution of an amino acid residue at a position corresponding to position 46 of SEQ ID NO:1 with a neutral amino acid having a side-chain surface area of 100 to 150 Å 2 or an acidic amino acid having a side-chain surface area of 100 to 150 Å 2 ; (c) a substitution of an amino acid residue at a position corresponding to position 96 of SEQ ID NO:1 with a basic amino acid; (d) a substitution of an amino acid residue at a position corresponding to position 172 of SEQ ID NO: 1 with an amino acid having a smaller side-chain surface area than Tyr; (e) a substitution of an amino acid residue at a position corresponding to position 196 of SEQ ID NO:1 with a basic amino acid; (f) a substitution of an amino acid residue at a position corresponding to position 312 of SEQ ID NO: 1 with an amino acid having a larger side-chain surface area than Ala; and (g) a substitution of an amino acid residue at a position corresponding to position 371 of SEQ ID NO: 1 with an aliphatic amino acid, an acidic amino acid, or an amino acid having a hydroxyl group-bearing side chain. 2. A vector comprising the DNA according to claim 1 . 3. A transformant obtained by transformation of a host cell with the vector according to claim 2 . 4. A culture of the transformant according to claim 3 . 5. The isolated DNA according to claim 1 , wherein the amino acid sequence contains at least one amino acid substitution selected from (a) to (g): (a) a substitution of an amino acid residue at a position corresponding to position 42 of SEQ ID NO:1 with Met; (b) a substitution of an amino acid residue at a position corresponding to position 46 of SEQ ID NO:1 with Ile; (c) a substitution of an amino acid residue at a position corresponding to position 96 of SEQ ID NO:1 with Arg or His; (d) a substitution of an amino acid residue at a position corresponding to position 172 of SEQ ID NO:1 with Ala or Ser; (e) a substitution of an amino acid residue at a position corresponding to position 196 of SEQ ID NO:1 with His; (f) a substitution of an amino acid residue at a position corresponding to position 312 of SEQ ID NO:1 with Ile; and (g) a substitution of an amino acid residue at a position corresponding to position 371 of SEQ ID NO:1 with Ala, Val, Ile, Glu, Ser, Thr, or Tyr. 6. An isolated DNA that encodes a protein which comprises an amino acid sequence identical to SEQ ID NO: 1 except for one or more substitutions selected from the group consisting of: (a) a substitution of Leu at position 42 of SEQ ID NO: 1 with an amino acid having a side-chain surface area of 100 to 200 Å 2 ; (b) a substitution of Met at position 46 of SEQ ID NO: 1 with a neutral amino acid having a side-chain surface area of 100 to 150 Å 2 or an acidic amino acid having a side-chain surface area of 100 to 150 Å 2 ; (c) a substitution of Asn at position 96 of SEQ ID NO: 1 with a basic amino acid; (d) a substitution of Tyr at position 172 of SEQ ID NO: 1 with an amino acid having a smaller side-chain surface area than Tyr; (e) a substitution of Thr at position 196 of SEQ ID NO: 1 with a basic amino acid; (f) a substitution of Ala at positon 312 with an amino acid having a larger side-chain surface area than Ala; and (g) a substitution of Phe at position 371 of SEQ ID NO: 1 with an aliphatic amino acid, an acidic amino acid, or an amino acid having a hydroxyl group-bearing side chain. 7. The isolated DNA according to claim 6 wherein said protein comprises an amino acid sequence identical to SEQ ID NO: 1 except for one or more substitutions selected from the group consisting of: (a) a substitution of Leu at position 42 of SEQ ID NO: 1 with Met; (b) a substitution of Met at position 46 of SEQ ID NO: 1 with Ile; (c) a substitution of Asn at position 96 of SEQ ID NO: 1 with Arg or His; (d) a substitution of Tyr at position 172 of SEQ ID NO: 1 with Ala or Ser; (e) a substitution of Thr at position 196 of SEQ ID NO: 1 with His; (f) a substitution of Ala at positon 312 with Ile; and (g) a substitution of Phe at position 371 of SEQ ID NO: 1 with Ala, Val, Ile, Glu, Ser, Thr, or Tyr. 8. An isolated DNA encoding a protein having an amino acid sequence selected from the amino acid sequences of SEQ ID Nos:2 and 4 to 19.
acting on hydrogen peroxide as acceptor (1.11) · CPC title
acting on NADH or NADPH (1.6) · CPC title
with oxygen as acceptor (1.6.3) · CPC title
Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title
Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.